Last updated on February 2018

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients


Brief description of study

Non-interventional, multicenter, prospective, European study to describe the effectiveness of trabectedin + PLD in the treatment of relapsed ovarian cancer (ROC) patients according to SmPC regardless of previous use of an antiangiogenic drug

Clinical Study Identifier: NCT02825420

Contact Investigators or Research Sites near you

Start Over

Medipole de Savoie

Challes Les Eaux, France
  Connect »

Brustzentrum

Wetzlar, Germany
  Connect »

Hospital Doctor Negr n

Las Palmas de Gran Canaria, Spain
  Connect »

Hospital Son Llatzer

Palma de Mallorca, Spain
  Connect »

Hospital Universitario de La Laguna

San Cristóbal de La Laguna, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.